Citations

Mayo Clinic

Showing 10 of 108523 citations.

Abstract B43: Role of activated SHP2 in high-risk neuroblastoma pathogenesis
Zhu, Shizhen , Look, A. Thomas , Neel, Benjamin G.

Cancer Research | May 1, 2015 | Volume: 74 | Issue: 20_Supplement | Pages: B43-B43

10.1158/1538-7445.pedcan-b43 Get It

Abstract Neuroblastoma, an embryonic tumor of peripheral sympathetic nervous system (PSNS), accounts for 10% of all childhood cancer deaths. We recently developed a robust zebrafish model of neuroblastoma and demonstrated that activated ALK synergizes with MYCN by inhibiting a developmentally-timed apoptotic response that is otherwise induced by MYCN. Genomic studies show that PTPN11 (encoding SHP2) is the second most frequently mutated genes in high-risk neuroblastoma. We have now used our zebrafish model to ask whether mutationally activated SHP2 functions as an oncogene in neuroblastoma. We developed transgenic lines in which ptpn11E69K is overexpressed in the PSNS under control of the dopamine-beta-hydroxylase promoter. Interestingly, ptpn11E69Ksynergized with MYCN to accelerate the onset of neuroblastoma in the interrenal gland, the zebrafish analogue of the adrenal medulla. Tumors began to appear at 15 weeks in transgenic fish overexpressing MYCN alone, whereas latency was shortened to 7 weeks and the penetrance was increased more than four-fold in transgenic fish co-expressing MYCN and ptpn11E69K. Co-expression of ptpn11E69K and MYCN also induced ganglioneuroma in the sympathetic ganglia, an outcome that has not been observed in transgenic fish overexpressing MYCN and activated ALK. These results suggest that activated SHP2 can collaborate with MYCN in neuroblastoma tumorigenesis via mechanisms different from those of activated ALK. Thus, zebrafish appears to provide a robust model system for functional genomic analysis and for the investigation of the mechanisms and pathways underlying mutations identified in ongoing tumor resequencing studies. Citation Format: (Jane) shizhen Zhu, Benjamin G. Neel, A. Thomas Look. Role of activated SHP2 in high-risk neuroblastoma pathogenesis. [abstract]. In: Proceedings of the AACR Special Conference on Pediatric Cancer at the Crossroads: Translating Discovery into Improved Outcomes; Nov 3-6, 2013; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2013;74(20 Suppl):Abstract nr B43.
Abstract 38: Using molecularly characterized patient-derived models to delineate underlying drivers and vulnerabilities of epithelial ovarian cancer
Topp, Monique, Hartley, Lynne, Cook, Michele , Heong, Valerie , McShane, Lauren, Pyman, Jan, McNally, Orla , Ananda, Sumi, Harell, Maria I., Etemadmoghadam, Dariush , Galletta, Laura, Mitchell, Gillian, Kerr, Jeff B., Kaufmann, Scott H. , (AOCS), Australian Ovarian Cancer Study, Wakefield, Matthew M., Boehm, Emma , Alsop, Kathryn , Fox, Stephen B. , Hutt, Karla J. , (AOCS), Australian Ovarian Cancer Study, Swisher, Elizabeth M. , Bowtell, David D.L. , Wakefield, Matthew, Scott, Clare L. , Kaufmann, Scott H

Cancer Research | May 1, 2015 | Volume: 74 | Issue: 23_Supplement | Pages: 38-38

10.1158/1538-7445.cansusc14-38 Get It

Abstract Background: Treatment options for women with ovarian cancer remain very limited and acquired resistance to current therapies is very common. Altered DNA repair capability in epithelial ovarian cancer (EOC) may underlie response to both standard therapy and novel treatments, such as PARP inhibitors. Molecular sub-classification of high-grade serous ovarian cancer (HG-SOC) may uncover potential drug targets and possible mechanisms of drug resistance. Understanding the contribution of DNA repair and other driver mutations to drug response and resistance requires the development of molecularly annotated preclinical models reflective of the clinic. Methods: A patient derived xenograft (PDX) cohort has been generated from consecutive, chemotherapy-naïve human HG-SOC and stratified according to in vivo response to standard chemotherapy, DNA repair capability and molecular characteristics, including next generation sequencing by Foundation Medicine. Resistance to therapy is driven by re-treating relapsed PDX in vivo providing invaluable “paired samples” (pre and post drug treatment), which are difficult to obtain from patients, to allow clonal evolution analysis of mechanisms of drug response and resistance. Results: The xenograft success rate was 83%. Of ten HG-SOC PDX, all exhibited mutations in TP53, five in BRCA1/2 (two of which were germline) and two were methylated for BRCA1. In vivo cisplatin response, determined as platinum sensitive (progression-free interval (PFI) ≥100 d, n=4), platinum resistant (PFI <100 d, n=3) or platinum refractory (n=3), was largely consistent with patient outcome. Three of four platinum sensitive HG-SOC PDX contained DNA repair gene mutations, and the fourth was methylated for BRCA1. In contrast, all three platinum refractory PDX overexpressed dominant oncogenes (CCNE1, LIN28B and/or BCL2). Molecular analysis of this cohort has revealed actionable targets for novel therapeutic strategies. In vivo studies, including with PARP inhibitors, are underway. Conclusion: PDX with histologic, molecular and therapeutic annotation, as well as clinical outcome data allow interrogation of molecular aberrations and drug resistance in vivo. This will inform targeting of novel therapies and the design of clinical trials for women. Citation Format: Monique D. Topp, Lynne Hartley, Michele Cook, Valerie Heong, Emma Boehm, Lauren McShane, Jan Pyman, Orla McNally, Sumi Ananda, Maria I. Harell, Dariush Etemadmoghadam, Laura Galletta, Kathryn Alsop, Gillian Mitchell, Stephen B. Fox, Jeff B. Kerr, Karla J. Hutt, Scott H. Kaufmann, Australian Ovarian Cancer Study (AOCS), Elizabeth M. Swisher, David D. Bowtell, Matthew M. Wakefield, Clare L. Scott. Using molecularly characterized patient-derived models to delineate underlying drivers and vulnerabilities of epithelial ovarian cancer. [abstract]. In: Proceedings of the AACR Special Conference: Cancer Susceptibility and Cancer Susceptibility Syndromes; Jan 29-Feb 1, 2014; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(23 Suppl):Abstract nr 38. doi:10.1158/1538-7445.CANSUSC14-38
Abstract A70: Vasodilator-stimulated phosphoprotein promotes TGF-beta mediated myofibroblastic activation by regulating recycling of TGF-beta receptor II to the plasma membrane
Tu, Kangsheng , Li, Jiachu, Shah, Vijay H. , Kang, Ningling , Liu, Chunsheng

Cancer Research | May 1, 2015 | Volume: 75 | Issue: 1_Supplement | Pages: A70-A70

10.1158/1538-7445.chtme14-a70 Get It

Abstract Introduction: Liver microenvironment is a critical determinant for development and progression of liver metastasis. Under TGF-β stimulation, hepatic stellate cells (HSCs), which are liver specific pericytes, transdifferentiate into myofibroblasts that promote tumor implantation and growth in the liver. The regulation of this HSC activation process in the liver however remains poorly understood. In this study, we tested a hypothesis that actin binding protein vasodilator-stimulated phosphoprotein (VASP), previously implicated in focal adhesion and migration of HSCs, may regulate the TGF-β mediated HSC activation process by interacting with and regulating TGF-β receptors. Methods: VASP shRNA and siRNA were used to knockdown VASP in primary human HSCs and LX2, an immortalized HSC cell line. TGF-β activation of HSCs was quantitated by immunofluorescence staining (IF) for alpha-smooth muscle actin (α-SMA) and Western blot analysis (WB) for α-SMA, fibronectin and P-SMAD2. Total TGF-β receptor levels were determined by WB, and plasma membrane TβRII was quantitated by biotinylation of cell surface proteins approach. Protein subcellular localization was investigated by IF and protein interactions were determined by double IF and co-immunoprecipitation (IP). Regulation of stellate cell VASP by HSC/tumor interactions was investigated by IF on human colorectal liver metastases and the role of stellate cell VASP in tumor growth was studied in a tumor/HSC coimplantation mouse model. Results: TGF-β1 induced more than 60% of human primary HSCs into myofibroblasts as determined by α-SMA IF. Two different VASP shRNAs significantly reduced this effect of TGF-β1 on HSC activation (P<0.05). The effect of VASP knockdown on HSC activation was confirmed in LX2 cells as well as using a VASP siRNA approach. VASP knockdown increased total TGF receptor protein levels with no effects on SMAD2 and 3 protein levels. VASP interacted with TβRII as evidenced by double IF and co-IP. Biotin-labeling of cell surface proteins and IF revealed that VASP knockdown reduced TβRII protein level at the plasma membrane and that VASP overexpression increased TβRII at the plasma membrane. Concurrently, VASP knockdown reduced plasma membrane localization of Rab11a, a small GTPase that marks recycling endosomes and is essential for recycling of plasma membrane receptors. VASP/Rab11 interactions were confirmed by IF and co-IP. Furthermore, we found that VASP knockdown HSCs significantly reduced tumor growth in mice as compared to control HSCs in a HSC/tumor coimplantation model. In patients, metastasis of colorectal cancer cells in liver sinusoids induced upregulation of VASP and α-SMA in adjacent HSCs as revealed by IF on biopsies of human colorectal liver metastases. Conclusions: Our studies demonstrate a requirement of VASP in the TGF-β dependent HSC activation in the tumor microenvironment and ensuing tumor growth. VASP interacts with Rab11 and regulates Rab11 positive recycling endosomal function thereby promoting TβRII recycling back to the plasma membrane in HSCs. VASP in the tumor microenvironment thus presents a therapeutic target for reducing tumor implantation and metastatic growth in the liver. Citation Format: Kangsheng Tu, Jiachu Li, Chunsheng Liu, Vijay H. Shah, Ningling Kang. Vasodilator-stimulated phosphoprotein promotes TGF-beta mediated myofibroblastic activation by regulating recycling of TGF-beta receptor II to the plasma membrane. [abstract]. In: Abstracts: AACR Special Conference on Cellular Heterogeneity in the Tumor Microenvironment; 2014 Feb 26-Mar 1; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2015;75(1 Suppl):Abstract nr A70. doi:10.1158/1538-7445.CHTME14-A70
Functional impact of diaphragm muscle sarcopenia in both male and female mice
Greising, Sarah M. , Mantilla, Carlos B. , Medina-Martínez, Juan S. , Stowe, Jessica M., Sieck, Gary C. , Sieck, Gary , Mantilla, Carlos B

American Journal of Physiology-Lung Cellular and Molecular Physiology | May 1, 2015 | Volume: 309 | Issue: 1 | Pages: L46-L52

10.1152/ajplung.00064.2015 | PMID 25934669 Get It

To perform a range of ventilatory and nonventilatory behaviors, the diaphragm muscle (DIAm) must be able to generate sufficient forces throughout the lifespan. We hypothesized that sarcopenia impacts DIAm force generation and thus limits performance of expulsive, higher force, nonventilatory behaviors. Male and female mice ( n = 79) at 6 and 24 mo of age (100 vs. 70–75% survival, respectively) were used to examine transdiaphragmatic pressure (Pdi) generation across motor behaviors in vivo and in vitro DIAm specific force. We found a significant effect of age on maximum Pdi (20–41% decline during tracheal occlusion and bilateral phrenic nerve stimulation), maximum DIAm specific force (30% decline), and DIAm fatigue resistance (15% increase). There were no differences between sexes in these age effects on DIAm performance. These results support our hypothesis that sarcopenia primarily impacts higher force, nonventilatory motor behaviors of the DIAm. Such functional limitations may have negative implications in the ability of the DIAm to generate forces needed for airway clearance in old age and thereby contribute to age-related respiratory complications.
Chronic Renal Ischemia in Humans: Can Cell Therapy Repair the Kidney in Occlusive Renovascular Disease?
Saad, Ahmed , Herrmann, Sandra M. , Textor, Stephen C., Herrmann, Sandra M

Physiology | May 1, 2015 | Volume: 30 | Issue: 3 | Pages: 175-182

10.1152/physiol.00065.2013 | PMID 25933818 Get It

Occlusive renovascular disease caused by atherosclerotic renal artery stenosis (ARAS) elicits complex biological responses that eventually lead to loss of kidney function. Recent studies indicate a complex interplay of oxidative stress, endothelial dysfunction, and activation of fibrogenic and inflammatory cytokines as a result of atherosclerosis, hypoxia, and renal hypoperfusion in this disorder. Human studies emphasize the limits of the kidney adaptation to reduced blood flow, eventually leading to renal hypoxia with activation of inflammatory and fibrogenic pathways. Several randomized prospective clinical trials show that stent revascularization alone in patients with atherosclerotic renal artery stenosis provides little additional benefit to medical therapy once these processes have developed and solidified. Experimental data now support developing adjunctive cell-based measures to support angiogenesis and anti-inflammatory renal repair mechanisms. These data encourage the study of endothelial progenitor cells and/or mesenchymal stem/stromal cells for the repair of damaged kidney tissue.
Transforming Medicine Through Physiology
Sieck, Gary C. , Sieck, Gary

Physiology | May 1, 2015 | Volume: 30 | Issue: 3 | Pages: 173-174

10.1152/physiol.00013.2015 | PMID 25933817 Get It

Three-dimensional finite difference models of shear wave propagation in isotropic, homogeneous soft tissue
Yang, Yiqun , McGough, Robert J., Urban, Matthew W.

Journal of the Acoustical Society of America | May 1, 2015 | Volume: 137 | Issue: 4_Supplement | Pages: 2365-2365

10.1121/1.4920593 Get It

Shear wave elastography with ultrasound applies an acoustic radiation force to generate shear waves in viscoelastic soft tissue. To address the need for more effective simulation tools that model shear waves generated by an applied acoustic radiation force, three-dimensional (3D) finite difference programs that simulate propagation of shear waves in an isotropic, homogeneous medium have been created. These programs simulate shear wave propagation in elastic and viscoelastic soft tissue models. The 3D finite difference implementation combines an explicit time-stepping approach and a staggered spatial grid with an absorbing boundary condition that reduces boundary reflections. The acoustic radiation force in these simulations is quickly and accurately simulated in FOCUS (http://www.egr.msu.edu/~fultras-web) for a focused linear ultrasound array with an f/# of 2. The compressional wave speed is 1500 m/s and the shear wave speed is 1.5m/s in the elastic and viscoelastic tissue models, and the shear viscosity is 1 Pa·s in the viscoelastic model. The simulation completes 90,000 time steps of a 10 ms simulation in an 80 mm × 80 mm × 80 mm region with spatial sampling equal to the wavelength of compressional component in three days on a 3.4 MHz Intel i7 processor. [Supported in part by NIH Grants R01EB012079 and R01DK092255.]
Simulation of ultrasound radiation force induced shear wave propagation in viscoelastic media using a mapped Chebyshev pseudospectral method
Qiang, Bo, McGough, Robert J., Greenleaf, James F. , Brigham, John C. , Urban, Matthew W.

Journal of the Acoustical Society of America | May 1, 2015 | Volume: 137 | Issue: 4_Supplement | Pages: 2364-2364

10.1121/1.4920589 Get It

We implemented a three-dimensional solver for simulating the ultrasound radiation force induced shear wave motion in viscoelastic media using a mapped Chebyshev pseudospectral method. The solver used a body force field that is simulated by the Field II program as the excitation. Then, a velocity-stress formulation was used to calculate the shear wave motion. We used a Voigt model to describe tissue viscoelasticity, and the viscosity is introduced by memory variables and auxiliary differential equations. The top boundary of the domain had a fixed boundary condition to mimic the interaction between an ultrasound probe and the tissue surface. All other sides of the domain were surrounded by perfectly matched layers to minimize the reflections. Time stepping was implemented with the LSODE integrator with variable step sizes. Results show that the waveform of the simulated shear wave is close to experimental observations and equivalent FEM simulations. We used a Fourier-based method to estimate the phase velocities of the shear waves between 100–1000 Hz and a nonlinear regression to estimate the Voigt model parameters. The reconstructions matched within 10% error compared with the true values.
Spatially uniform harmonic acoustic radiation force excitation using one-dimensional linear array
Bayat, Mahdi , Alizad, Azra , Fatemi, Mostafa

Journal of the Acoustical Society of America | May 1, 2015 | Volume: 137 | Issue: 4_Supplement | Pages: 2314-2315

10.1121/1.4920447 Get It

Low frequency harmonic force excitation can be used for both imaging and tissue characterization. This type of excitation can be achieved via intersecting two beams that slightly differ in frequency. One requirement of this technique is creating focused intersecting beams using available hardware. Previous studies have suggested different configurations for creating harmonic radiation force using linear arrays. However, these methods rely on identical frequency response assumption across all elements of the aperture. In practice, this assumption can be easily violated, especially if the transmit frequencies are not around the center frequency of the probe. When using electronic steering and focusing at different locations, this can result in a non-uniform radiation force pattern due to frequency changes in the sub-aperture. When used for vibro-acoustography, this manifests as vertical streaks in the final image that can severely degrade the quality of the image. We present a novel technique that minimizes element transmit frequency switching which in turn results in a more uniform excitation intensity. The results of applying this aperture configuration for vibro-acoustography imaging of breast phantoms with hard inclusions show significant improvements over previous methods. [This work was supported by NIH Grant R01 EB17213.]
Transition to turbulence in acoustically driven flows
Thompson, Charles , Chandra, Kavitha , Denis, Max , Mehta, Vineet

Journal of the Acoustical Society of America | May 1, 2015 | Volume: 137 | Issue: 4_Supplement | Pages: 2223-2223

10.1121/1.4920098 Get It

Direct numerical solutions of the three-dimensional time-dependent Navier-Stokes equation are presented for the evolution of three-dimensional finite-amplitude disturbances in the Stokes boundary layer. The basic flow is driven harmonically in time and the disturbances represent a departure from the basic state of the fluid. For fixed value of the fluid viscosity, instability is shown to be a function of the amplitude of oscillation of the basic flow, excitation frequency, and the channel wall geometry. Special attention is given to pressure gradient and surface wave driven flows. Conditions for instability and transition are outlined.